Delivery Order SPE2DB22D9239-SPE2DB24FDE38
- Not listed
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order against its indefinite delivery contract with the Defense Logistics Agency to provide 4562945987 units of Entyvio 300 mg vials. The $48,122.70 order has a completion date of December 18, 2023 and was awarded on November 27, 2023. DMS Pharmaceutical Group is a woman-owned small business and woman-owned business located in Park Ridge, Illinois that holds numerous contracts to supply pharmaceutical and medical products...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order against the Defense Logistics Agency Troop Support Medical pharmaceutical prime vendor contract to provide 4563107239 ENTYVIO 300 MG VIALS with a potential value of $57,747.24. The delivery order has a completion date of January 5, 2024 and was awarded on December 13, 2023. DMS Pharmaceutical Group will deliver the pharmaceutical products to facilities located in Park Ridge, Illinois. As a woman-owned small business...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at thirty-eight thousand four hundred ninety-eight dollars and sixteen cents ($38,498.16) by the Defense Logistics Agency. This order was issued against DMS Pharmaceutical Group's indefinite delivery contract to supply pharmaceuticals and medical supplies to the Defense Logistics Agency, with a potential value of up to five million dollars through December 2025. Under this order, DMS Pharmaceutical Group will...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order against the Defense Logistics Agency Troop Support Medical indefinite delivery contract for $48,122.70 to provide 4562642070 ENTYVIO 300 MG VIALS. The delivery order has a completion date of November 17, 2023 and was awarded on October 26, 2023. DMS Pharmaceutical Group Inc. will supply the pharmaceutical items to Defense Logistics Agency Troop Support Medical facilities in Park Ridge, Illinois. No set-aside...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at $9,624.54 from the Defense Logistics Agency to provide 4562801359 ENTYVIO 300 MG VIALS. This delivery order was issued against DMS Pharmaceutical Group's existing indefinite delivery contract with the Defense Logistics Agency to supply pharmaceuticals and medical supplies with a potential value of up to $5 million through December 2025. As a woman-owned small business and pharmaceutical wholesaler, DMS...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at $19,249.08 by the Defense Logistics Agency to provide 4562850265 ENTYVIO 300 MG VIALS. The delivery order was issued against DMS Pharmaceutical Group's existing indefinite delivery contract with the Defense Logistics Agency to supply pharmaceuticals and medical supplies with a potential value of up to $5 million through December 2025. No set-aside designation was used for this award. DMS Pharmaceutical...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at $48,122.70 by the Defense Logistics Agency to provide 4562986926 units of Entyvio 300 mg vials. The delivery order was awarded on November 30, 2023 under DMS Pharmaceutical Group's indefinite delivery contract with the Defense Logistics Agency to supply pharmaceuticals and medical supplies with a potential value of up to $5 million through December 2025. As a woman-owned small business and pharmaceutical...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order against the Defense Logistics Agency Troop Support Medical pharmaceutical prime vendor contract to provide 4562612628 ENTYVIO 300 MG VIALS. The order has a potential value of $44,398.90 and requires completion by November 15, 2023. As the prime contractor, DMS Pharmaceutical Group will supply the specified pharmaceutical item to Defense Logistics Agency Troop Support Medical facilities from its location in Park...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order against the Defense Logistics Agency Troop Support Medical pharmaceutical prime vendor contract to provide 4563079611 ENTYVIO 300 MG VIALS. The $28,873.62 order has a completion date of January 3, 2024 and was awarded on December 11, 2023 without a set-aside designation. DMS Pharmaceutical Group will deliver the pharmaceutical products to facilities supported by the Defense Logistics Agency located in Park Ridge,...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at twenty-four thousand sixty-one dollars and thirty cents ($24,061.30) by the Defense Logistics Agency to provide Entyvio 300 mg vials. The delivery order was issued against an existing indefinite delivery contract held by DMS Pharmaceutical Group with the Defense Logistics Agency for pharmaceutical supplies with a potential value of up to five million dollars through December 2025. No set-aside...
- SPE2DB22D9239Indefinite Delivery Contract
- SPE2DB22D9239-SPE2DB24FDE38Delivery Order
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order against its indefinite delivery contract with the Defense Logistics Agency to provide 4562852688, described as EnTyvio 300 mg vials. The $86,620.68 order is for delivery to Park Ridge, Illinois by December 7, 2023. DMS Pharmaceutical Group holds this indefinite delivery contract through December 2025 to supply pharmaceuticals and medical supplies to various Defense Logistics Agency locations, with a potential value of up to $5 million. As a woman-owned small business, DMS Pharmaceutical Group has a long history of supporting the Defense Logistics Agency's medical treatment facilities worldwide through contracts for specialized pharmaceutical products and direct pharmaceutical prime vendor services.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $86.6k | 11/15/23 |